Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Clifton E. Hyman is active.

Publication


Featured researches published by Clifton E. Hyman.


Tetrahedron Letters | 1999

Solid phase synthesis of 1,3,5-trisubstituted pyridin-2-ones

James A. Linn; Samuel W. Gerritz; Anthony L. Handlon; Clifton E. Hyman; Dennis Heyer

Abstract The solid phase synthesis of 1,3,5-trisubsituted pyridin-2-ones is reported via selective 1 NH- alkylation of 3-amino-5-carbomethoxy-1 H -pyridin-2-one with a solid-supported halo-acid. Coupling of an acid to solid-supported 3-aminopyridinone was followed by saponification of the methyl ester to give the acid. Activation of the acid via the pentafluorophenyl ester allowed reaction with an amine, and cleavage from the solid support with TFA:H 2 O (95:5) provided 1,3,5-trisubstituted pyridin-2-ones.


Archive | 2002

Pyrimidinones as melanin concentrating hormone receptor 1

Andrew J. Carpenter; Joel P. GlaxoSmithKline C Oper; Anthony L. Handlon; Donald L. Hertzog; Clifton E. Hyman; Yu C. Glaxosmithkline Guo; Jason D. Speake; David Witty


Archive | 1998

Hypolipidemic bicyclic derivatives

Anthony L. Handlon; Gordon Lewis Hodgson; Clifton E. Hyman


Archive | 2004

Heterocyclic mchr1 antagonists

Kevin K Barvian; Andrew J. Carpenter; Joel P. Cooper; Paul L. Feldman; Yu C. Guo; Anthony L. Handlon; Donald L. Hertzog; Clifton E. Hyman; Andrew J. Peat; Gregory Peckham; Jason D. Speake; William R Swain; Francis X. Tavares; Huiqiang Zhou


Archive | 2004

3-(4-AMINOPHENYL)THIENOPYRIMID-4-ONE DERIVATIVES AS MCH R1 ANTAGONISTS FOR THE TREATMENT OF OBESITY, DIABETES, DEPRESSION AND ANXIETY

Kevin K Barvian; Anthony L. Handlon; Donald L. Hertzog; Clifton E. Hyman


Archive | 2003

Condensed heterocyclic compounds as calcitonin agonists

Ashok Bhandari; Eric E. Boros; David John Cowan; Anthony L. Handlon; Clifton E. Hyman; Jeffrey Alan Oplinger; Michael H. Rabinowitz; Philip Stewart Turnbull


Journal of Heterocyclic Chemistry | 1986

A Galactoside Derivative of a Nitrosoisocytosine Inhibitor of Dihydropteroate Synthase: Synthesis and Biological Evaluation.

O. W. Jun. Lever; Clifton E. Hyman; P. H. Ray; R. Ferone; J. E. Kelsey


Journal of Pharmaceutical Sciences | 1984

Synthesis of Bridged Catechol-Homocysteine Derivatives as Potential Inhibitors of Catechol O-Methyltransferase

O. William Lever; Clifton E. Hyman; Helen L. White


Archive | 2007

Arylamine mch r1 antagonists

Kevin K Barvian; Anthony L. Handlon; Donald L. Hertzog; Clifton E. Hyman


Archive | 2004

Derives de 3-(4-aminophenyl)-thienopyrimid-4-one utilises comme antagonistes de mch r1 pour le traitement de l'obesite, du diabete, de la depression et de l'anxiete

Kevin K Barvian; Anthony L. Handlon; Donald L. Hertzog; Clifton E. Hyman

Collaboration


Dive into the Clifton E. Hyman's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

R. Ferone

Research Triangle Park

View shared research outputs
Top Co-Authors

Avatar

Yu C. Guo

Research Triangle Park

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge